Fetal Diagnosis and Therapy
Elevated Interferon-Alpha in Fetal Blood in the Prenatal Diagnosis of Aicardi-Goutières SyndromeDesanges C.a · Lebon P.b · Bauman C.a · Vuillard E.a · Garel C.a · Cordesse A.c · Oury J.F.a · Crow Y.d · Luton D.aaDépartement de Périnatologie, Hôpital Robert Debré, Université Denis Diderot, Paris; bService de Virologie, Hôpital Cochin St Vincent de Paul, Université René Descartes, Paris; cService de Gynécologie-Obstétrique, Centre Hospitalier de Gonesse, Gonesse, France, and dDepartment of Clinical Genetics, Ashley Wings, St James University Hospital, Leeds, UK
|
|
Fetal Diagn Ther 2006;21:153–155
Log in to MyKarger to check if you already have access to this content.
KAB
Buy a Karger Article Bundle (KAB) and profit from a discount!
If you would like to redeem your KAB credit, please log in.
Save over 20% compared to the individual article price.
* The final prices may differ from the prices shown due to specifics of VAT rules.
Article / Publication Details
First-Page Preview
Received: January 26, 2005
Accepted: May 09, 2005
Published online: December 15, 2005
Issue release date: December 2005
Number of Print Pages: 3
Number of Figures: 0
Number of Tables: 0
ISSN: 1015-3837 (Print)
eISSN: 1421-9964 (Online)
For additional information: https://www.karger.com/FDT
Abstract
A case of Aicardi-Goutières syndrome is described in a family with index cases. The diagnosis was made prenatally based on high fetal blood concentration of interferon alpha. The biological measurement could be of interest for further diagnosis of other cases.
© 2006 S. Karger AG, Basel
Related Articles:
References
- Aicardi J, Goutières F: A progressive familial encephalopathy in infancy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis. Ann Neurol 1984;15:49–54.
- Black DN, Watters GV, Andermann E, et al: Encephalitis among Cree children in northern Quebec. Ann Neurol 1988;24:483–489.
- Tolmie JL, Shillito P, Hugues-Benzie R, Stephenson JB: The Aicardi-Goutières syndrome: familial early onset encephalopathy with calcifications of the basal ganglia and chronic cerebrospinal fluid lymphocytosis. J Med Genet 1995;32:881–884.
- Goutières F, Aicardi J, Barth PG, Lebon P: Aicardi-Goutières syndrome: an update and results of Interferon-alpha studies. Ann Neurol 1998;44:900–907.
- Lebon P, Badoual J, Ponsot G, Goutières F, Hemeury-Cukier F, Aicardi J: Intrathecal synthesis of interferon alpha in infants with progressive familial encephalopathy. J Neurol Sci 1988;84:201–208.
-
Lebon P, Meritet JF, Krivine A, Rozenberg F: Interferon and Aicardi-Goutières syndrome. Eur J Pediatr Neurol 2002;6(suppl A):47–53.
External Resources
-
Lebon P, Meritet JF, Krivine A, Rozenberg F, Daffos F, Dommergues M, Dumez Y, Forrestier F, Mandelbrot L, Poissonnier MH, Pons JC: Infections virales in utero; in Geneup RP (ed): Virus et grossesse, 7ème séminaire. Paris, Guigoz, 1992, pp 81–94.
-
Krivine A, Tovey M, Taty-Taty R, Lebon P: Endogenous interferon alpha in newborns from seropositive mothers. J Interferon Res 1992;12(suppl 1):151.
- Faure S, Bordelais I, Marquette C, Rittey C, Campos-Castello J, Goutières F, Ponsot G, Weissenbach J, Lebon P: Aicardi-Goutières syndrome: monogenic recessive disease, genetically heterogeneous disease or multifactorial disease? Clin Genet 1999;56:149–153.
- Crow YJ, Jackson AP, Roberts E, et al: Aicardi Goutières syndrome displays genetic heterogeneity with one locus AGS1 on chromosome 3p21. Am J Hum Genet 2000;67:213–221.
- Crow Y, Black D, Ali Manir, Bond J, Jackson AP, Lefson M, Michaud J, Roberts E, Stephenson JBP, Woods G, Lebon P: Cree encephalitis is allelic with Aicardi-Goutières syndrome: implications for the pathogenesis of disorders of interferon alpha metabolism. J Med Genet 2003;40:183–188.
- Palmer P, Charley B, Rombaud B, Daëron M, Lebon P: Antibody-dependent induction of type I interferons by poliovirus in human mononuclear blood cells required the type II Fcg receptor. Virology 1999;278:86–94.
- Kumar D, Rittey C, Cameron AH, Variend S: A recognizable inherited syndrome of progressive central nervous system degeneration and generalized intracranial calcification with overlapping phenotype of the syndrome of Aicardi and Goutières. Am J Med Genet 1998;75:508–515.
- McEntagart M, Kamel H, Lebon P, King MD: Aicardi-Goutières syndrome: an expanding phenotype. Neuropediatrics 1998;29:163–167.
-
Aicardi J: Aicardi-Goutières syndrome: special type early-onset encephalopathy. Eur J Paediatr Neurol 2002;6(suppl A):A1–7.
External Resources
-
Lanzi G, Fazzi E, D’Arrigo S, Aicardi-Goutières syndrome: a description of 21 new cases and a comparison with the literature. Eur J Paediatr Neurol 2002;6(suppl A):A9–22.
External Resources
- Le Garrec M, Doret M, Pasquier JC, Till M, Lebon P, Buernerd A, Escalon J, Gaucherand P: Prenatal diagnosis of Aicardi-Goutières syndrome. Prenat Diagn 2005;25:28–30.
- Lebon P, Daffos F, Checoury A, Grangeot-Keros L, Forestier F, Toublanc JE: Presence of an acid-labile alpha-interferon in sera from fetuses and children with congenital rubella. J Clin Microbiol 1985;21:775–778.
- Dommergues M, Mahieu-Caputo D, Fallet-Bianco C, Delezoide Al, Aubry MC, Mirlesse V, Narcy F, Kahn AP, Dumez Y, Lebon P: Fetal serum interferon-alpha suggests viral infection as the etiology of unexplained bilateral cerebral ventriculomegaly. Prenat Diagn 1996;16:883–892.
- Akwa Y, Hassett DE, Eloranta ML, et al: Transgenic expression of interferon-alpha in the central nervous system of mice protects against lethal neurotropic viral infection but induces inflammation and neurodegeneration. J Immunol 1998;161:5016–5026.
- Campbell IL, Krucker T, Steffensen S, Akwa Y, Powell HC, Lane T, Carr DJ, Gold HG, Henriksen SJ, Siggins GR: Structural and functional neuropathology in transgenic mice with CNS expression of IFN-alpha. Brain Res 1999;835:46–61.
Article / Publication Details
First-Page Preview
Received: January 26, 2005
Accepted: May 09, 2005
Published online: December 15, 2005
Issue release date: December 2005
Number of Print Pages: 3
Number of Figures: 0
Number of Tables: 0
ISSN: 1015-3837 (Print)
eISSN: 1421-9964 (Online)
For additional information: https://www.karger.com/FDT
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Get Permission
PubMed ID
